Published Date: 02 Mar 2023
Recommendations from SCAI experts support the safety of PCI without on-site surgery
Read Full NewsHere's some of what is coming soon to NeurologyLive® this week.
Allison B. Reiss, MD, associate professor of medicine at NYU Grossman Long Island School of Medicine discussed the often-overlooked early signs of early-onset Alzheimer disease.
Gefurulimab (Klygefa), a once-weekly, self-administered complement C5 inhibitor from Alexion and AstraZeneca, is now approved in the US for adults with AChR-antibody-positive generalized myasthenia gravis.
A new FDA filing seeks to expand cenobamate's epilepsy indication to primary generalized tonic-clonic seizures, based on positive phase 3 trial data.
The professor of neurology at UT Southwestern Medical Center discussed emerging trials, proposed changes to myelitis diagnostic criteria and nomenclature, and the unmet needs raised by patients at this year’s symposium.
A new global phase 2 trial, TARBELA-AD, will test RG6434, Roche's investigational oral NLRP3 inflammasome inhibitor, in adults with early symptomatic Alzheimer disease.
A pivotal phase 2/3 trial of Zhimeng Biopharma's CB03-154, an oral KCNQ2/3 potassium channel opener, has completed enrollment in amyotrophic lateral sclerosis.
1.
The main subject is associated with suicide in the United States.
2.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
3.
Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study
4.
Minimally invasive prostate cancer treatment shows success in first patient
5.
Cancer patients rarely use ancestry testing.
1.
Citizen-Centered Digital Health Navigation Systems: Advancing Patient Engagement and Optimizing Healthcare Delivery
2.
AI-Assisted Real-Time Tumor Mapping During Surgery: Transforming Intraoperative Oncology
3.
Pediatric Advances in Mapping Hematopoietic Development During Childhood
4.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
5.
Pediatric Red-Cell Membrane Remodeling With Age: Mechanisms, Clinical Implications, and Management
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
3.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
4.
Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2
5.
Cancer Care: From Awareness to Recovery
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation